Literature DB >> 15000348

Neuregulin 1 and schizophrenia.

Hreinn Stefansson1, Valgerdur Steinthorsdottir, Thorgeir E Thorgeirsson, Jeffrey R Gulcher, Kari Stefansson.   

Abstract

We discuss in this review the role of the neuregulin (NRG1) gene in schizophrenia. NRG1 contributes to the genetics of schizophrenia in both Icelandic and Scottish schizophrenia patients. NRG1 participates in glutamatergic signaling by regulating the N-methyl-D-aspartate (NMDA) receptor through the interaction of the NRG1 protein and its receptors. NRG1 plays a central role in neural development and is most likely involved in regulating synaptic plasticity, or how the brain responds or adapts to the environment. The discovery that defects in NRG1 signaling may be involved in some cases of schizophrenia, not only implicates NRG1, but suggests that its biological pathway, active both at developing and mature synapses, is worth inspecting further in a search for other schizophrenia genes possibly in epistasis with NRG1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15000348     DOI: 10.1080/07853890310017585

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  35 in total

Review 1.  Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and development.

Authors:  Christina Wilson; Alvin V Terry
Journal:  Clin Schizophr Relat Psychoses       Date:  2010-07

Review 2.  Schizophrenia: an update and review.

Authors:  Jehannine Austin
Journal:  J Genet Couns       Date:  2005-10       Impact factor: 2.537

3.  Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas.

Authors:  Tilo Kircher; Renate Thienel; Michael Wagner; Martina Reske; Ute Habel; Thilo Kellermann; Ingo Frommann; Sibylle Schwab; Wolfgang Wölwer; Martina von Wilmsdorf; Dieter F Braus; Andrea Schmitt; Alexander Rapp; Tony Stöcker; N Jon Shah; Fritz A Henn; Heinrich Sauer; Wolfgang Gaebel; Wolfgang Maier; Frank Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

4.  A Src link in schizophrenia.

Authors:  Chang-Gyu Hahn
Journal:  Nat Med       Date:  2011-04       Impact factor: 53.440

Review 5.  The genetics of schizophrenia and bipolar disorder: dissecting psychosis.

Authors:  N Craddock; M C O'Donovan; M J Owen
Journal:  J Med Genet       Date:  2005-03       Impact factor: 6.318

Review 6.  Cannabis and psychosis/schizophrenia: human studies.

Authors:  Deepak Cyril D'Souza; Richard Andrew Sewell; Mohini Ranganathan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-16       Impact factor: 5.270

7.  [The genetic revolution-impact on therapy and prevention].

Authors:  P Propping; S Aretz
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

Review 8.  Copy variations in schizophrenia and bipolar disorder.

Authors:  H M Lachman
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

9.  Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors.

Authors:  Chongbo Zhong; Chuang Du; Melissa Hancock; Marjolijn Mertz; David A Talmage; Lorna W Role
Journal:  J Neurosci       Date:  2008-09-10       Impact factor: 6.167

10.  Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

Authors:  Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-12       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.